EVEXEve Holding, Inc.Industrials · Aerospace & Defenseas of 2026-09-16
Horizon

Issued 2026-09-16 at $1.99 · now $1.99 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, EVEX has typically landed between $1.43 and $2.65 — a range of −28.1% to +33.4% from the issuance price $1.99.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

1,408 overlapping 1 month windows · 2021-01-07 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($1.99) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where EVEX has typically landed a month from the 2026-09-16 close of $1.99 — the range is history, not a prediction.

$1.43worst · -28.1%$2.65best · +33.4%
  • now $1.99 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $1.97 (-1.1%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $1.74–$2.2
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $1.43–$2.65
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,408 windows spanning 2021-01-07 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2025-07-23−45.6%−45.6%+0.0%
2025-07-24−44.0%−45.0%+0.0%
2025-08-05−43.0%−43.0%+0.0%
3 best
2022-08-25+76.3%−13.5%+77.6%
2022-08-23+73.2%−15.1%+74.4%
2022-08-24+73.2%−11.3%+82.1%

1,408 overlapping windows · 2021-01-07 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
20%
−5.1%
n=5
Feb
17%
−13.9%
n=6
Mar
33%
−2.5%
n=6
Apr
83%
+5.3%
n=6
May
67%
+8.4%
n=6
Jun
50%
−2.6%
n=6
Jul
17%
−2.8%
n=6
Aug
17%
−15.4%
n=6
Sep
67%
+8.6%
n=6
Oct
60%
+3.0%
n=5
Nov
20%
−0.1%
n=5
Dec
80%
+4.2%
n=5

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$6$2↑ buys↓ sales
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

17 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-06-09Bordais JohannofficerAward / grant128,795277,009Form 4
2026-06-09Couto Eduardo SiffertofficerAward / grant135,339354,729Form 4
2026-06-09Galvao de Oliviera SimoneofficerAward / grant24,36755,143Form 4
2026-05-09Lima Uallace MoreiradirectorAward / grant42,12048,183Form 4
2026-05-09BLAKEY MARION CdirectorAward / grant56,391157,498Form 4
2026-05-09Eremenko PauldirectorAward / grant56,391157,498Form 4
2026-05-09DEMURO GERARD JdirectorAward / grant56,391587,398Form 4
2026-05-09Pedreiro SergiodirectorAward / grant56,391157,498Form 4
2026-02-01Lima Uallace MoreiradirectorAward / grant6,0636,063Form 4
2025-09-30EMBRAER S.A.directorAward / grant4,123,711250,523,300Form 4
2025-05-09Pedreiro SergiodirectorAward / grant42,858101,107Form 4
2025-05-09DEMURO GERARD JdirectorAward / grant42,858531,007Form 4
2025-05-09Bordais JohannofficerAward / grant74,535148,214Form 4
2025-05-09BLAKEY MARION CdirectorAward / grant42,858101,107Form 4
2025-05-09Cordon MariadirectorAward / grant42,85892,794Form 4
2025-05-09Couto Eduardo SiffertofficerAward / grant102,858219,390Form 4
2025-05-09Eremenko PauldirectorAward / grant42,858101,107Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.